Activation of NF-kB by DNA-damaging anticancer agents, including ionizing radiation (IR), has emerged as an important modulator of malignant cell behaviors, such as resistance to apoptotic cell death. This signal transduction pathway also serves as a paradigm to understand how nuclear DNA damage may induce nucleus-to-cytoplasmic signal transduction pathways. We have previously discovered a novel nucleus-to-cytoplasmic NF-kB signaling pathway induced by IR and other agents that can induce DNA double strand breaks (DSBs). This signaling pathway involves a post-translational modification (PTM) of NEMO (NF-kB essential modulator)/IKK3, the regulatory subunit of the I:B kinase (IKK) complex, by SUMO-1 (small ubiquitin-like modifier 1). We now generated a novel NemoDK knockin mice harboring a germ-line mutation of the sumoylation sites. In the current proposal, we will establish the physiological importance of this new NF-kB signaling pathway in response to IR by directly evaluating the role of NEMO sumoylation in vivo and further dissect the critical upstream and downstream mechanisms. The following three aims will address our central hypothesis that NEMO sumoylation plays a critical physiological role in mediating NF-kB activation by IR to modulate radiation sensitivity in vivo:
Aim 1 : Determine the roles of NEMO sumoylation in modulating radiation sensitivity in vivo.
Aim 2 : Reveal the upstream role of NEMO zinc finger in promoting NEMO sumoylation.
Aim 3. Elucidate SUMO-1 specific downstream regulation of NEMO function. We believe that the proposed research is important for two major reasons. First, the described research will uncover novel NF-kB signal transduction mechanisms in response to DNA damage stimuli. Second, understanding the mechanisms of NF-kB activation by DNA damaging agents may help identify novel drug targets to improve the current methods of cancer therapy.
Many anticancer agents, including ionizing radiation (IR), are used to kill cancer cells, but unfortunately they also turn on cancer cell survival mechanisms in cancer cells that counter the death effect. One of these mechanisms is the activation of the transcription factor NF-kB that rapidly turns on the synthesis of survival genes. The proposed research will uncover important mechanisms involved in this activation, which will help identify novel drug targets to improve the current methods of cancer therapy.
|Jackson, Shawn S; Oberley, Christopher; Hooper, Christopher P et al. (2015) Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-?B signaling. Exp Cell Res 331:58-72|
|Shin, Eun Myoung; Hay, Hui Sin; Lee, Moon Hee et al. (2014) DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest 124:3807-24|
|Berry, Scott M; Chin, Emily N; Jackson, Shawn S et al. (2014) Weak protein-protein interactions revealed by immiscible filtration assisted by surface tension. Anal Biochem 447:133-40|
|Jackson, Shawn S; Coughlin, Emma E; Coon, Joshua J et al. (2013) Identifying post-translational modifications of NEMO by tandem mass spectrometry after high affinity purification. Protein Expr Purif 92:48-53|
|McCool, Kevin W; Miyamoto, Shigeki (2012) DNA damage-dependent NF-*B activation: NEMO turns nuclear signaling inside out. Immunol Rev 246:311-26|
|Wu, Lixian; Shao, Lijian; An, Ningfei et al. (2011) IKK* regulates the repair of DNA double-strand breaks induced by ionizing radiation in MCF-7 breast cancer cells. PLoS One 6:e18447|
|Miyamoto, Shigeki (2011) Nuclear initiated NF-?B signaling: NEMO and ATM take center stage. Cell Res 21:116-30|
|Lee, Moon-Hee; Miyamoto, Shigeki (2011) Expanding NF?B and SUMO ties. Cell Cycle 10:3983-4|
|Wuerzberger-Davis, Shelly M; Chen, Yuhong; Yang, David T et al. (2011) Nuclear export of the NF-?B inhibitor I?B? is required for proper B cell and secondary lymphoid tissue formation. Immunity 34:188-200|
|Yang, Yibin; Xia, Fang; Hermance, Nicole et al. (2011) A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol Cell Biol 31:2774-86|
Showing the most recent 10 out of 30 publications